05/29/2025
Let’s talk about what’s really happening behind the scenes when people can’t access GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound.
With rising costs, shortages, and insurance denials, many are turning to alternative or unregulated options — but what does that mean for your safety?
This live is focused on education, harm reduction, and awareness only.
We’re sharing insights from a trusted community member about what to expect, what to avoid, and how people are trying to protect themselves when traditional access fails.
We do NOT endorse, recommend, or sell any unregulated or grey market products.
This is not medical or legal advice. Always talk to a licensed healthcare provider.
If you're on a GLP-1 journey, using compounded semaglutide or tirzepatide, or struggling to access care — this conversation is for you.
Let’s talk about red flags, misinformation, and the reality so many are facing when trying to manage obesity, PCOS, or type 2 diabetes.
� New to streaming or looking to level up? Check out StreamYard and get $10 discount! �